GranuFlo Recall Claims Mount, as Filings in Federal Proceeding Near 2,600, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous GranuFlo lawsuit clients who allegedly suffered heart attacks, strokes and other dangerous cardiovascular events following administration of GranuFlo or NaturaLyte during dialysis treatments.

Free Case Review
We are not at all surprised that GranuFlo lawsuits continue to be filed in this litigation at a fairly steady pace.

GranuFlo recall (http://www.granuflolawsuit2014.com/granuflo-dialysis-recall/) claims filed on behalf of individuals who were allegedly harmed by GranuFlo and NaturaLyte dialysis concentrates continue to mount in the federal litigation now underway in U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP reports. According to an Updated Docket Report issued by the U.S. Judicial Panel on Multidistrict Litigation on January 15th, at least 2,575 GranuFlo lawsuits are now pending in the proceeding. This represents an increase of 286 filings since the release of the Panel’s previous update on December 15th, 2014, when 2,289 cases were reported. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“Our Firm is representing numerous individuals in this proceeding, and we continue to hear from others who allegedly suffered heart attacks, strokes and other serious cardiovascular evens due to the use of GranuFlo and NaturaLyte during dialysis treatments. As such, we are not at all surprised that GranuFlo lawsuits continue to be filed in this litigation at a fairly steady pace,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently evaluating GranuFlo and NaturaLyte lawsuits on behalf of individuals who were allegedly injured by the dialysis medications.

GranuFlo and NaturaLyte Recall
The GranuFlo litigation has been growing since June 2012, when the U.S. Food and Drug Administration (FDA) announced a Class I recall for GranuFlo and NaturaLyte, two dialysis concentrate manufactured by Fresenius Medical Care. The agency announced the recall after Fresenius issued an Urgent Product Notification in March 2012 that warned of dosage issues that could put patients at risk for metabolic alkalosis, a dangerous elevation in the blood’s bicarbonate levels which can result in serious, and potentially life-threatening, cardiovascular event. In addition to the federal cases, almost 4,000 lawsuits that put forth similar allegations have been consolidated in Massachusetts Middlesex County Superior Court since GranuFlo and NaturaLyte were recalled. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O).

According to court documents, all of the complaints pending in Massachusetts federal court accuse Fresenius of failing to provide adequate warnings regarding the serious cardiovascular risks associated with GranuFlo and NaturaLyte, and of aggressively marketing the concentrates even after those dangers became known. Among other things, the lawsuits point to a 2011 internal memo in which Fresenius notified dialysis clinics in its own network about the dosage adjustments needed to ensure the safety of patients treated with GranuFlo and NaturaLyte. Plaintiffs question why Fresenius waited until March 2012 to inform thousands of other facilities that also used the two products about this serious concern.

Dialysis patients who experienced life-threatening cardiovascular events that were allegedly caused by GranuFlo or NaturaLyte may be entitled to join this growing litigation. To learn more about filing a GranuFlo lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.granuflolawsuit2014.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website